Overview

Geographic Atrophy Treatment Evaluation

Status:
Terminated

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to evaluate the safety and efficacy of AL-8309B Ophthalmic Solution versus Vehicle administered as a topical ocular drop for the treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Phase:

Phase 3

Details

Lead Sponsor:

Alcon Research

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions